• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (BROKEN BOW) SEE H.10; BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (BROKEN BOW) SEE H.10; BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Catalog Number 367964
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/18/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that while using bd vacutainer® pst¿ gel and lithium heparinn (lh) 126 units blood collection tubes, there are high ast results in an unspecified number of tubes across multiple lot numbers.Lot numbers were not provided.No patient impact reported.The following information was provided by the initial reporter: "customer is reporting that they had continuous issue with high ast's in pst tubes.We are experiencing high ast across all lots, we have been having an issue since spring 2022.How many individuals were affected 20-50 patients per day.".
 
Additional Manufacturer Narrative
D1: medical device brand name: bd vacutainer® pst¿ gel and lithium heparinn (lh) 126 units blood collection tubes.H.6.Investigation summary: material #: 367964 lot/batch #: 3016665 bd had received 5 samples and no photos for evaluation.The customer samples along with 100 retention samples of the incident lot from bd inventory were evaluation and no issues were observed.A clinical evaluation was not required for this erroneous results complaint as information regarding this situation is outlined in the limitations section of the ifu (instructions for use).For tubes subjected to centrifugation to generate plasma or serum for testing, standard processing conditions do not necessarily completely sediment all cells, whether or not barrier gel is present.Cell-based metabolism, as well as natural degradation ex vivo, can continue to affect serum/plasma analyte concentrations/activities after centrifugation.Separated plasma samples in particular, will have a gradient of cells and platelets present after centrifugation.The presence of cells and platelets in the plasma may lead to increased variability and/or instability of certain analytes that are involved in cell/platelet-mediated metabolic processes and/or are present in higher concentrations in cells or platelets.Analytes that may be affected include aspartate aminotransferase (ast), glucose, inorganic phosphorus, lactate dehydrogenase and potassium.The magnitude of such effects may vary depending on several factors, including whether the plasma is aliquoted or remains in the primary tube, sample agitation, and time.Analyte stability should be evaluated for the storage containers and conditions of each laboratory based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure mode erroneous results-ast.Bd was not able to identify a root cause for the indicated failure mode.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SEE H.10
Common Device Name
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer (Section G)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17952354
Report Number1917413-2023-01025
Device Sequence Number6790129
Product Code JKA
UDI-Device Identifier50382903679640
UDI-Public50382903679640
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K945952
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 10/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date01/31/2024
Device Catalogue Number367964
Device Lot Number3016665
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/03/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/18/2023
Initial Report FDA Received Date10/17/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/16/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-